Lung clearance index predicts pulmonary exacerbations in young patients with cystic fibrosis

Thorax

Volumn 69, Issue 1, 2014, Pages 39-45

  Vermeulen, François ^a   Proesmans, Marijke ^a   Boon, Mieke ^a   Havermans, Trudy ^a   De Boeck, Kris ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BIOMETRY; CF QUESTIONNAIRE REVISED; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG CLEARANCE; LUNG CLEARANCE INDEX; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RESPIRATORY TRACT PARAMETERS; SPIROMETRY; SYMPTOM; YOUNG ADULT;

CYSTIC FIBROSIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY GAS EXCHANGE; SPIROMETRY; VITAL CAPACITY; YOUNG ADULT;

EID: 84890309789     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2013-203807     Document Type: Article

References (35)

1. Corey M. Power considerations for studies of lung function in cystic fibrosis. Proc Am Thorac Soc 2007;4:334-7.
2. Fuchs SI, Ellemunter H, Eder J, et al. Feasibility and variability of measuring the Lung Clearance Index in a multi-center setting. Pediatr Pulmonol 2012;47:649-57.
3. Singer F, Kieninger E, Abbas C, et al. Practicability of nitrogen multiple-breath washout measurements in a pediatric cystic fibrosis outpatient setting. Pediatr Pulmonol 2013;48:739-46.
4. Robinson PD, Latzin P, Verbanck S, et al . Consensus statement for inert gas washout measurement using multiple- and single- breath tests. Eur Respir J 2013;41:507-22.
5. Singer F, Houltz B, Latzin P, et al. A realistic validation study of a new nitrogen multiple-breath washout system. PLoS One 2012;7:e36083.
6. Fuchs SI, Sturz J, Junge S, et al. A novel sidestream ultrasonic flow sensor for multiple breath washout in children. Pediatr Pulmonol 2008;43:731-8.
7. Fuchs SI, Eder J, Ellemunter H, et al. Lung clearance index: normal values, repeatability, and reproducibility in healthy children and adolescents. Pediatr Pulmonol 2009;44:1180-5.
8. Gustafsson PM, De Jong PA, Tiddens HA, et al. Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis. Thorax 2008;63:129-34.
9. Owens CM, Aurora P, Stanojevic S, et al. Lung Clearance Index and HRCT are complementary markers of lung abnormalities in young children with CF. Thorax 2011;66:481-8.
10. Robinson PD, Cooper P, Van Asperen P, et al. Using index of ventilation to assess response to treatment for acute pulmonary exacerbation in children with cystic fibrosis. Pediatr Pulmonol 2009;44:733-42.
11. Amin R, Subbarao P, Jabar A, et al. Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function. Thorax 2010;65:379-83.
12. Amin R, Subbarao P, Lou W, et al. The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis. Eur Respir J 2011;37:806-12.
13. Subbarao P, Stanojevic S, Brown M, et al. Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis: a pilot study using inhaled hypertonic saline. Am J Respir Crit Care Med 2013;188:456-60.
14. Davies JC, Sheridan H, Lee P-S, et al. Effect of ivacaftor on lung function in subjects with cystic fibrosis who have the G551D-CFTR mutation and mild lung disease: a comparison of lung clearance index (LCI) vs. spirometry [abstract]. J Cyst Fibros 2012;11(Suppl 1):S15.
15. Aurora P, Stanojevic S, Wade A, et al . Lung clearance index at 4 years predicts subsequent lung function in children with cystic fibrosis. Am J Respir Crit Care Med 2011;183:752-8.
16. Vermeulen F, Ophoff J, Proesmans M, et al. Does lung clearance index predict time to pulmonary excerbation? J Cyst Fibros 2012;11(Suppl 1):S14.
17. Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 2012;40:1324-43.
18. Roelants M, Hauspie R, Hoppenbrouwers K. References for growth and pubertal development from birth to 21 years in Flanders, Belgium. Ann Hum Biol 2009;36:680-94.
19. Smyth A, Elborn JS. Exacerbations in cystic fibrosis: 3 - Management. Thorax 2008;63:180-4.
20. Quittner AL, Sawicki GS, McMullen A, et al . Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national sample. Qual Life Res 2012;21:1267-78.
21. Klijn PH, van Stel HF, Quittner AL, et al. Validation of the Dutch cystic fibrosis questionnaire (CFQ) in adolescents and adults. J Cyst Fibros 2004;3:29-36.
22. Kanga J, Kuhn R, Craigmyle L, et al. Cystic fibrosis clinical score: a new scoring system to evaluate acute pulmonary exacerbation. Clin Ther 1999;21:1343-56.
23. Lee TW, Brownlee KG, Conway SP, et al. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2003;2:29-34.
24. Goss CH, Burns JL. Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis. Thorax 2007;62:360-7.
25. Bilton D, Canny G, Conway S, et al. Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials. J Cyst Fibros 2011;10(Suppl 2):S79-81.
26. Waters V, Stanojevic S, Atenafu EG, et al. Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis. Eur Respir J 2012;40:61-6.
27. Hegarty M, Macdonald J, Watter P, et al. Quality of life in young people with cystic fibrosis: effects of hospitalization, age and gender, and differences in parent/child perceptions. Child Care Health Dev 2009;35:462-8.
28. Quittner AL, Schechter MS, Rasouliyan L, et al. Impact of socioeconomic status, race, and ethnicity on quality of life in patients with cystic fibrosis in the United States. Chest 2010;137:642-50.
29. Loeve M, Gerbrands K, Hop WC, et al. Bronchiectasis and pulmonary exacerbations in children and young adults with cystic fibrosis. Chest 2011;140:178-85.
30. Tepper LA, Utens E, Caudri D, et al. Impact of bronchiectasis and trapped air on quality of life and exacerbations in CF. Eur Respir J 2013;42:371-9.
31. Bakker EM, van der Meijden JC, Nieuwhof EM, et al. Determining presence of lung disease in young children with cystic fibrosis: lung clearance index, oxygen saturation and cough frequency. J Cyst Fibros 2012;11:223-30.
32. Kraemer R, Blum A, Schibler A, et al. Ventilation inhomogeneities in relation to standard lung function in patients with cystic fibrosis. Am J Respir Crit Care Med 2005;171:371-8.
33. Bakker EM, Borsboom GJ, van der Wiel-Kooij EC, et al. Small airway involvement in cystic fibrosis lung disease: routine spirometry as an early and sensitive marker. Pediatr Pulmonol Published Online First: 13 Feb 2013. doi: 10.1002/ppul.22777.
34. Horsley AR, Gustafsson PM, Macleod KA, et al. Lung clearance index is a sensitive, repeatable and practical measure of airways disease in adults with cystic fibrosis. Thorax 2008;63:135-40.
35. Corey M, Farewell V. Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am J Epidemiol 1996;143:1007-17.